9,10-dimethyl-1,2-benzanthracene has been researched along with medroxyprogesterone in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (68.42) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kosaka, A; Yamashita, A | 1 |
| Grönroos, M; Kangas, L | 1 |
| Iino, Y; Ishikawa, H; Izuo, M; Ogawa, T; Takikawa, H; Yoshida, M | 1 |
| Ashino-Fuse, H; Hiragun, A; Iwaguchi, T; Oikawa, T; Tominaga, T; Yoshida, Y | 1 |
| Iino, Y; Ishikawa, H; Izuo, M; Takikawa, H | 2 |
| Dupuis, M; Gimotty, P; Russo, IH; Russo, J | 1 |
| Dauvois, S; Labrie, F; Spinola, PG | 1 |
| Kitamura, M; Kosaki, G; Tominaga, T; Yoshida, Y | 1 |
| Barbi, GP; Boccardo, F; Dandolo, G; De Menech, R; Guarneri, D; Moro, MG; Paganuzzi, M; Pino, G; Sanguineti, M; Zanardi, S | 1 |
| Conti, G; Crispino, A; Di Carlo, F; Gallo, E; Racca, S | 1 |
| Itoh, I; Kitamura, M; Saito, T; Tominaga, T | 1 |
| Falautano, P; Filippeschi, S; Malfiore, C; Noseda, S; Serraglia, N; Spreafico, F | 1 |
| Arai, T; Endo, K; Hirai, T; Iino, Y; Ishikawa, H; Izuo, M; Kawai, T; Ogawa, T; Takikawa, H; Yamazaki, K | 1 |
| Casazza, AM; di Marco, A; di Salle, E; Pollini, C; Zaccheo, T | 1 |
| Arai, T; Endo, K; Hoshino, K; Iino, Y; Ishida, T; Ishikawa, H; Ogawa, T; Takahashi, T; Yamazaki, K; Yokoe, T | 1 |
| Bai, R; Beildeck, ME; Glazer, RI; Kopelovich, L; Russell, RG; Xie, Z; Yin, Y | 1 |
| Suckow, M; Welsh, J; Zinser, GM | 1 |
| Chen, EP; Chodosh, LA; Fitzgerald, GA; Lawson, JA; Markosyan, N; Ndong, VN; Smyth, EM; Sterner, CJ; Yao, Y | 1 |
19 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and medroxyprogesterone
| Article | Year |
|---|---|
[Experimental study of combination medical endocrine therapy on DMBA-induced mammary tumor, with special reference to the effect of drug-dose on various factors].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Organ Size; Rats; Tamoxifen | 1992 |
Antitumor effects of combination toremifene and medroxyprogesterone acetate (MPA) in vitro and in vivo.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Estrogen Antagonists; Female; Humans; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Neoplasms; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Toremifene; Tumor Cells, Cultured | 1990 |
Effects of sequential and combined endocrine therapies on the growth of 7,12-dimethylbenz [alpha] anthracene-induced rat mammary carcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovariectomy; Rats; Rats, Inbred Strains; Tamoxifen | 1990 |
Angiogenic activity of rat mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene and its inhibition by medroxyprogesterone acetate: possible involvement of antiangiogenic action of medroxyprogesterone acetate in its tumor growth inhibition.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cells, Cultured; Drug Interactions; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Neovascularization, Pathologic; Rats; Rats, Inbred Strains | 1988 |
Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Drug Therapy, Combination; Estradiol; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1989 |
Effect of medroxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aging; Animals; Drug Administration Schedule; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Rats; Rats, Inbred Strains; Weight Gain | 1989 |
Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Drug Synergism; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone | 1989 |
Effective sequential administration of tamoxifen and medroxyprogesterone acetate for 7,12-dimethylbenz[a-anthracene-induced rat mammary tumors in relation to hormone receptors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Drug Administration Schedule; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Rats; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Time Factors | 1985 |
[Combined therapies with medroxyprogesterone acetate (MPA) in DMBA-induced rat mammary cancer].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Estrogens; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Rats; Rats, Inbred Strains; Tegafur | 1986 |
Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Estradiol; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Rats; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1985 |
Effects of medroxyprogesterone acetate on DMBA-induced mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cytoplasm; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Rats; Receptors, Estrogen; Receptors, Progesterone | 1985 |
Effects of hexestrol, medroxyprogesterone acetate and chlormadinone acetate on 7, 12-dimethylbenz [a] anthracene-induced rat mammary cancer in relation to estrogen receptor.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Body Weight; Chlormadinone Acetate; Delayed-Action Preparations; Female; Hexestrol; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Rats; Rats, Inbred Strains; Receptors, Estrogen | 1981 |
Effect of medroxyprogesterone acetate on DMBA-induced rat mammary carcinoma and on immunological reactivity.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Female; Immunity; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Neoplasms, Hormone-Dependent; Rats | 1982 |
[Effect of medroxyprogesterone acetate (MAP) and vitamin C on DMBA induced rat mammary cancer in relation to estrogen receptor(ER)].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Ascorbic Acid; Female; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Nandrolone; Rats; Rats, Inbred Strains; Receptors, Estrogen | 1983 |
Combined and sequential treatment using FCE 21336, a new prolactin-lowering drug, and medroxyprogesterone acetate (MPA) in DMBA-induced tumors in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Castration; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Prolactin; Rats; Rats, Inbred Strains | 1984 |
[Changes of hormone receptor status in various treatment for human breast cancer and DMBA tumor of the rat].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Rats; Receptors, Estrogen; Receptors, Progesterone | 1984 |
Characterization of medroxyprogesterone and DMBA-induced multilineage mammary tumors by gene expression profiling.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Immunohistochemistry; Mammary Neoplasms, Experimental; Medroxyprogesterone; Mice; RNA, Messenger | 2005 |
Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Epidermis; Female; Lymphoid Tissue; Male; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone; Mice; Mice, Knockout; Receptors, Calcitriol; Survival Analysis; Vitamin D | 2005 |
Deletion of cyclooxygenase 2 in mouse mammary epithelial cells delays breast cancer onset through augmentation of type 1 immune responses in tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Blotting, Western; Carcinogens; Cells, Cultured; Contraceptives, Oral, Synthetic; Cyclooxygenase 2; Cytokines; Eicosanoids; Epithelial Cells; Female; Immunoenzyme Techniques; Inflammation Mediators; Macrophages; Macrophages, Peritoneal; Male; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone; Mice; Mice, Knockout; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Th1 Cells | 2011 |